Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DPEP1 | P16444 | Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) | EnzymesFDA approved drug targetsMetabolic proteins | Bacterial infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 32 | 0.63 | |||
| CTL1 | Q8WWI5 | Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) | CD markersDisease related genesMetabolic proteins | 9 | Fusion and delivery mediationMetabolism mediation | 31 | 0.63 | |||
| BCAM | P50895 | Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239) | Blood group antigen proteinsCD markersPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 27 | 0.63 | |||
| SPP2A | Q8TCT8 | Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2) | Disease related genesEnzymesHuman disease related genes | 9 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 27 | 0.63 | |||
| LSAMP | Q13449 | Limbic system-associated membrane protein (LSAMP) (IgLON family member 3) | Metabolism mediation | 25 | 0.63 | |||||
| EPHA4 | P54764 | Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK) | Cancer-related genesEnzymesPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 24 | 0.63 | ||
| CELR2 | Q9HCU4 | Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3) | Essential proteinsG-protein coupled receptorsPredicted membrane proteins | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 22 | 0.63 | |||
| APLP2 | Q06481 | Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2) (APLP-2) (CDEI box-binding protein) (CDEBP) (Sperm membrane protein YWK-II) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 21 | 0.63 | |||
| ANXA1 | P04083 | Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26] | Cancer-related genesFDA approved drug targetsPlasma proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | ||||
| CD48 | P09326 | CD48 antigen (B-lymphocyte activation marker BLAST-1) (BCM1 surface antigen) (Leukocyte antigen MEM-102) (SLAM family member 2) (SLAMF2) (Signaling lymphocytic activation molecule 2) (TCT.1) (CD antigen CD48) | CD markersPlasma proteinsPredicted membrane proteins | Fusion and delivery mediationImmune mediation | 10 | 0.63 | ||||
| GBB2 | P62879 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2) | Disease related genesHuman disease related genesPotential drug targets | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | ||||
| LHPL2 | Q6ZUX7 | LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein) | Predicted membrane proteins | 4 | Fusion and delivery mediation | 10 | 0.63 | |||
| MARCS | P29966 | Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL) | Plasma proteinsPredicted intracellular proteins | Chronic obstructive pulmonary diseaseLung cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | |||
| OCLN | Q16625 | Occludin | Disease related genesHuman disease related genesPotential drug targets | 4 | Fusion and delivery mediationReceptor-signaling mediation | 10 | 0.63 | |||
| RPGF2 | Q9Y4G8 | Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1) | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 10 | 0.63 | |||||
| SGCE | O43556 | Epsilon-sarcoglycan (Epsilon-SG) | 1 | Adhesion and uptake mediation | 10 | 0.63 | ||||
| TRPV2 | Q9Y5S1 | Transient receptor potential cation channel subfamily V member 2 (TrpV2) (Osm-9-like TRP channel 2) (OTRPC2) (Vanilloid receptor-like protein 1) (VRL-1) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 10 | 0.63 | |||
| BTK | Q06187 | Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) | Cancer-related genesDisease related genesEnzymes | COVID-19Leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | |||
| CLC5A | Q9NY25 | C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1) (MDL-1) | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | ||||
| CR1 | P17927 | Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35) | Blood group antigen proteinsCD markersPlasma proteins | 1 | Retinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | ||
| EDNRA | P25101 | Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Anxiety disorderCardiac arrhythmiaCardiovascular disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | ||
| EPN1 | Q9Y6I3 | Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 9 | 0.63 | ||||
| FNBP1 | Q96RU3 | Formin-binding protein 1 (Formin-binding protein 17) (hFBP17) | Disease related genesPlasma proteinsPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 9 | 0.63 | ||||
| FZD1 | Q9UP38 | Frizzled-1 (Fz-1) (hFz1) (FzE1) | Cancer-related genesG-protein coupled receptorsPlasma proteins | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 9 | 0.63 | |||
| ICAM1 | P05362 | Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Conjunctiva disorderCrohn diseaseIndeterminate colitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 |